Cargando…
Effects of hypoxia on bone metabolism and anemia in patients with chronic kidney disease
BACKGROUND: Abnormal bone metabolism and renal anemia seriously affect the prognosis of patients with chronic kidney disease (CKD). Existing studies have mostly addressed the pathogenesis and treatment of bone metabolism abnormality and anemia in patients with CKD, but few have evaluated their mutua...
Autores principales: | Kan, Chao, Lu, Xu, Zhang, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686129/ https://www.ncbi.nlm.nih.gov/pubmed/35004993 http://dx.doi.org/10.12998/wjcc.v9.i34.10616 |
Ejemplares similares
-
Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
por: Kaplan, Joshua M., et al.
Publicado: (2018) -
Relationships between blood bone metabolic biomarkers and anemia in patients with chronic kidney disease
por: Li, Fan, et al.
Publicado: (2023) -
Hypoxia and chronic kidney disease
por: Wang, Bin, et al.
Publicado: (2022) -
Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates
por: Habas, Elmukhtar, et al.
Publicado: (2023) -
The role of hypoxia-inducible factor stabilizers in the treatment of anemia in patients with chronic kidney disease
por: Zhong, Hongzhen, et al.
Publicado: (2018)